VANI
Vivani Medical Inc.
NASDAQ: VANI · HEALTHCARE · BIOTECHNOLOGY
$1.34
+1.52% today
Updated 2026-04-30
Market cap
$115.97M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.43
Dividend yield
—
52W range
$1 – $2
Volume
0.3M
WallStSmart proprietary scores
16
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$4.83
+260.67%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-6.99M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-13.89M | $-25.65M | $-23.49M | $-26.61M | $-6.63M |
| EPS | — | — | — | — | $-0.43 |
| Free cash flow | $-19.13M | $-24.59M | $-21.34M | $-25.49M | $-6.99M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Vivani Medical Inc. trades at $1.34. Our Smart Value Score of 16/100 indicates the stock is weak.
Frequently asked questions
What is Vivani Medical Inc.'s stock price?
Vivani Medical Inc. (VANI) trades at $1.34.
Is Vivani Medical Inc. overvalued?
Smart Value Score 16/100 (Grade F, Strong Sell).
What is the price target of Vivani Medical Inc. (VANI)?
The analyst target price is $4.83, representing +260.7% upside from the current price of $1.34.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-159.60%
Beta3.37
50D MA$1.19
200D MA$1.34
Shares out0.08B
Float0.04B
Short ratio—
Avg volume0.3M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—